Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

An Open Label, Balanced, Randomized, Single Dose, Two Treatment, Two Sequence, Two Period, Two Way Crossover, Oral Bioequivalence Study of Test Product (T) of Ertugliflozin/Metformin 7.5 mg/ 1000 mg Film Coated Tablets of Humanis Sağlık A.Ş., Ç.O.S.B. Karaağaç Mahallesi Fatih Bulvarı No:32 Kapaklı/TEKİRDAĞ and Reference Product (R) of Segluromet 7.5 mg/ 1000 mg Film Coated Tablets of Merck Sharp & Dohme B.V., Waarderweg 39, 2031 BN Haarlem, The Netherlands, in Healthy, Adult, Human Subjects Under Fed Condition.

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT07266779
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:28:52.394203+00:00
Published At
2025-12-05T00:00:00+00:00
Record Updated At
2025-12-05
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Type 2 Diabetes"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-12-05"
protocolSection.identificationModule.nctId
"NCT07266779"
protocolSection.identificationModule.officialTitle
"An Open Label, Balanced, Randomized, Single Dose, Two Treatment, Two Sequence, Two Period, Two Way Crossover, Oral Bioequivalence Study of Test Product (T) of Ertugliflozin/Metformin 7.5 mg/ 1000 mg Film Coated Tablets of Humanis Sa\u011fl\u0131k A.\u015e., \u00c7.O.S.B. Karaa\u011fa\u00e7 Mahallesi Fatih Bulvar\u0131 No:32 Kapakl\u0131/TEK\u0130RDA\u011e and Reference Product (R) of Segluromet 7.5 mg/ 1000 mg Film Coated Tablets of Merck Sharp \u0026 Dohme B.V., Waarderweg 39, 2031 BN Haarlem, The Netherlands, in Healthy, Adult, Human Subjects Under Fed Condition."
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Type 2 Diabetes (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.